Synthesis and antitumor efficacy of biodegradable hollow mesoporous carbon nanocarriers | Synapse
March 3, 2026
Synthesis and antitumor efficacy of biodegradable hollow mesoporous carbon nanocarriers
Key Points
The biodegradable hollow mesoporous carbon nanocarriers demonstrate significant antitumor efficacy in cancer models, and complement existing therapies.
Key findings indicate enhanced drug delivery and targeted release of therapeutic agents with these nanocarriers, increasing effective treatment.
Assessment using synthesis techniques establishes the optimal conditions for producing these nanocarriers in a controlled laboratory setting.
This work highlights the potential of biodegradable nanocarriers in cancer therapy, requiring further investigation in clinical settings.